Acadia Pharmaceuticals buy Deutsche Bank Aktiengesellschaft
Start price
21.05.25
/
50%
€19.69
Target price
21.05.26
€30.98
Performance (%)
17.50%
Price
12.12.25
€23.13
Summary
This prediction is currently active. The prediction currently has a performance of 17.50%. This prediction currently runs until 21.05.26. The prediction end date can be changed by Deutsche_Bank_Aktien at any time. Deutsche_Bank_Aktien has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Acadia Pharmaceuticals | -1.867% | -1.867% |
| iShares Core DAX® | 0.734% | -0.964% |
| iShares Nasdaq 100 | -2.686% | -2.409% |
| iShares Nikkei 225® | -2.261% | -4.038% |
| iShares S&P 500 | -1.346% | -1.510% |
Comments by Deutsche_Bank_Aktien for this prediction
In the thread Acadia Pharmaceuticals diskutieren
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) had its price target raised by analysts at Deutsche Bank Aktiengesellschaft to $35.00. They now have a "buy" rating on the stock.
Ratings data for ACAD provided by MarketBeat